Related Experiment Videos
[CNS prophylaxis in acute lymphoblastic leukemia (author's transl)]
Anales Espanoles De Pediatria
|January 1, 1980
Summary
Central nervous system (CNS) prophylaxis in 43 pediatric acute lymphoblastic leukemia (LLA) patients showed no significant difference between cranial irradiation and craniospinal irradiation methods. Both approaches demonstrated mild side effects, with meningosis occurring in 13% of cases.
Area of Science:
- Pediatric Oncology
- Hematology
- Neuro-oncology
Context:
- Acute lymphoblastic leukemia (LLA) is a common childhood cancer.
- Central nervous system (CNS) involvement is a significant concern in LLA.
- Effective CNS prophylaxis is crucial for improving outcomes in pediatric LLA patients.
Purpose:
- To evaluate the effectiveness and safety of two CNS prophylaxis methods in pediatric LLA patients.
- To compare intrathecal methotrexate with cranial irradiation versus craniospinal irradiation.
Summary:
- This study analyzed 43 pediatric LLA patients receiving CNS prophylaxis.
- Treatments included intrathecal methotrexate combined with either cranial or craniospinal irradiation.
- Both methods showed comparable effectiveness, with 13% experiencing meningosis. Side effects were generally mild, including fever, vomiting, and somnolence. Severe complications were rare (sepsis, necrotizing leukoencephalopathy).
Impact:
- Findings suggest comparable efficacy between cranial and craniospinal irradiation for CNS prophylaxis in pediatric LLA.
- The study highlights the generally mild side effect profile of these treatments.
- Results contribute to optimizing CNS prophylaxis strategies in pediatric oncology, balancing efficacy with patient safety.